ORL
Diagnostic Value of Plasma Antidiuretic Hormone, Electrocochleography, and Glycerol Test in Patients with Endolymphatic HydropsTaguchi D.a, b · Kakigi A.b, c · Takeda T.b · Sawada S.b · Nakatani H.baDivision of Otolaryngology, Head and Neck Surgery, Tottori University Faculty of Medicine, Tottori, bDepartment of Otolaryngology, Kochi Medical School, Kochi, and cDepartment of Otolaryngology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: February 24, 2010
Issue release date: February 2010
Number of Print Pages: 4
Number of Figures: 3
Number of Tables: 1
ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)
For additional information: https://www.karger.com/ORL
Abstract
Objective: To investigate the relationship between the plasma antidiuretic hormone (p-ADH) level, electrocochleogram (ECoG), and the glycerol test in patients with endolymphatic hydrops (ELH). Patients and Methods: The subjects were 60 patients, including 51 with Ménière’s disease (except for cochlear Ménière’s disease), 7 with delayed ELH, and 2 with syphilitic ELH. The time period for measurements of the p-ADH level, ECoG and the glycerol test was within 4 weeks. Results: 13 patients showed positive results for all tests. 58 patients showed positive results for at least one of three tests. Only 2 patients showed negative results for all tests. Conclusion: The p-ADH level, ECoG and the glycerol test show different selectivity of ELH detection. It is useful to perform all three tests to diagnose ELH.
© 2010 S. Karger AG, Basel
Related Articles:
References
- Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H, Nakata S, Katayama N, Ishida IM: Visualization of endolymphatic hydrops in patients with Ménière’s disease. Laryngoscope 2007;117:415–420.
- Ferraro JA, Durrant JD: Electrocochleography in the evaluation of patients with Ménière’s disease/endolymphatic hydrops. J Am Acad Audiol 2006;17:45–68.
- Orchik DJ, Shea JJ Jr, Ge X: Transtympanic electrocochleography in Ménière’s disease using clicks and tone-bursts. Am J Otol 1993;14:290–294.
- Stahle J: Medical treatment of fluctuant hearing loss in Ménière’s disease. Am J Otol 1984;5:529–533.
- Takeda T, Kakigi A, Saito H: Antidiuretic hormone and endolymphatic hydrops. Acta Otolaryngol Suppl (Stockh) 1995;519:219–222.
- Takeda T, Takeda S, Kitano H, Okada T, Kakigi A: Endolymphatic hydrops induced by chronic administration of vasopressin. Hear Res 2000;140:1–6.
- Sawada S, Takeda T, Kitano H, Takeuchi S, Kakigi A, Azuma H: Aquaporin-2 regulation by vasopressin in the rat inner ear. Neuroreport 2002;13:1127–1129.
- Fukushima K, Takeda T, Kakigi A, Takeda S, Sawada S, Nishioka R, Azuma H, Taguchi T: Effects of lithium on endolymph homeostasis and experimentally induced endolymphatic hydrops. ORL J Otorhinolaryngol Relat Spec 2005;67:282–288.
-
Watanabe I: Ménière’s disease. With special emphasis on epidemiology, diagnosis and prognosis. ORL 1980;42:20–45.
External Resources
-
Moffat DA, Ballagh RH: Ménière’s disease; in Booth JB (ed): Scott-Brown’s Otolaryngology. Oxford, Butterworth-Heinemann, 1997, pp 1–50.
- Futaki T, Kitahara M, Morimoto M: A comparison of the furosemide and glycerol tests for Ménière’s disease: with special reference to the bilateral lesion. Acta Otolaryngol (Stockh) 1977;83:272–278.
-
Mizukoshi K, Watanabe Y, Ito M, Aso S, Kobayashi H, Shojaku H: The clinical significance of the furosemide VOR test for Ménière’s disease; in Kaufman Arenberg I (eds): Inner Ear Surgery. Amsterdam, Kugler, 1991, pp 161–165.
- Kimura H, Aso S, Watanabe Y: Prediction of progression from atypical to definite Ménière’s disease using electrocochleography and glycerol and furosemide tests. Acta Otolaryngol 2003;123:388–395.
- Mori N, Asai A, Suizu Y, Ohta K, Matsunaga T: Comparison between electrocochleography and glycerol test in the diagnosis of Ménière’s disease. Scand Audiol 1985;14:209–213.
- Ito M, Watanabe Y, Shojaku H, Kobayashi H, Aso S, Mizukoshi K: Furosemide VOR test for the detection of endolymphatic hydrops. Acta Otolaryngol Suppl (Stockh) 1993;504:55–57.
- Takeda T, Sawada S, Takeda S, Kitano H, Suzuki M, Kakigi A, Takeuchi S: The effects of V2 antagonist (OPC-31260) on endolymphatic hydrops. Hear Res 2003;182:9–18.
- Takeda T, Takeda S, Kakigi A, Okada T, Nishioka R, Taguchi D: A comparison of dehydration effects of V2 antagonist (OPC-31260) on the inner ear between systemic and round window applications. Hear Res 2006;218:89–97.
Article / Publication Details
Published online: February 24, 2010
Issue release date: February 2010
Number of Print Pages: 4
Number of Figures: 3
Number of Tables: 1
ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)
For additional information: https://www.karger.com/ORL
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
PubMed ID
